Incomplete HPV Vaccination among Individuals Aged 27–45 Years in the United States: A Mixed-Effect Analysis of Individual and Contextual Factors

Background: In the United States, the human papillomavirus (HPV) vaccine is approved for use in individuals up to age 45. Individuals 15 years and older require three doses of the vaccine to complete the recommended dosing series. Incomplete HPV vaccination rates (i.e., one or two doses) among those...

Descripción completa

Detalles Bibliográficos
Autores principales: Adekanmbi, Victor, Guo, Fangjian, Hsu, Christine D., Shan, Yong, Kuo, Yong-Fang, Berenson, Abbey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142711/
https://www.ncbi.nlm.nih.gov/pubmed/37112732
http://dx.doi.org/10.3390/vaccines11040820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142711/
https://www.ncbi.nlm.nih.gov/pubmed/37112732
http://dx.doi.org/10.3390/vaccines11040820

Ejemplares similares